Cora Ricker
Overview
Explore the profile of Cora Ricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillani R, Shulman D, DelRocco N, Klega K, Han R, Krailo M, et al.
medRxiv
. 2025 Feb;
PMID: 39974064
Purpose: Identification of discrete sub-groups associated with treatment response and resistance in localized Ewing sarcoma (EWS) remains a challenge. The primary objective of the Children's Oncology Group biology study AEWS18B1-Q...
2.
Stratified analysis identifies HIF-2 as a therapeutic target for highly immune-infiltrated melanomas
Huang A, Burke K, Porter R, Meiger L, Fatouros P, Yang J, et al.
bioRxiv
. 2024 Nov;
PMID: 39554029
While immune-checkpoint blockade (ICB) has revolutionized treatment of metastatic melanoma over the last decade, the identification of broadly applicable robust biomarkers has been challenging, driven in large part by the...
3.
Sehgal K, Pappa T, Shin K, Schiantarelli J, Liu M, Ricker C, et al.
JAMA Oncol
. 2024 Oct;
10(12):1663-1671.
PMID: 39446365
Importance: Aggressive thyroid carcinoma, including radioiodine refractory (RAIR) differentiated thyroid carcinoma (DTC), medullary thyroid carcinoma (MTC), and anaplastic thyroid carcinoma (ATC), are associated with significant morbidity and mortality and have...
4.
Bakouny Z, Sadagopan A, Ravi P, Metaferia N, Li J, Abuhammad S, et al.
Cell Rep
. 2022 Jan;
38(1):110190.
PMID: 34986355
Translocation renal cell carcinoma (tRCC) is a poorly characterized subtype of kidney cancer driven by MiT/TFE gene fusions. Here, we define the landmarks of tRCC through an integrative analysis of...
5.
Rafiei S, Fitzpatrick K, Liu D, Cai M, Elmarakeby H, Park J, et al.
Cancer Res
. 2020 Mar;
80(11):2094-2100.
PMID: 32127357
Alterations in DNA damage response (DDR) genes are common in advanced prostate tumors and are associated with unique genomic and clinical features. ATM is a DDR kinase that has a...